DiscoverJAMA Editors' SummaryMonoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalimab Without Concurrent Cisplatin for Nasopharyngeal Carcinoma, Weather Disasters and Drug Manufacturing, and more
Monoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalimab Without Concurrent Cisplatin for Nasopharyngeal Carcinoma, Weather Disasters and Drug Manufacturing, and more

Monoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalimab Without Concurrent Cisplatin for Nasopharyngeal Carcinoma, Weather Disasters and Drug Manufacturing, and more

Update: 2025-08-22
Share

Description

Editor’s Summary by Kirsten Bibbins-Domingo, PhD, MD, MAS, Editor in Chief, and Preeti Malani, MD, MSJ, Deputy Editor of JAMA, the Journal of the American Medical Association, for articles published from August 16-22 2025.

Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Monoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalimab Without Concurrent Cisplatin for Nasopharyngeal Carcinoma, Weather Disasters and Drug Manufacturing, and more

Monoclonal Antibody for Severe Chronic Rhinosinusitis, Toripalimab Without Concurrent Cisplatin for Nasopharyngeal Carcinoma, Weather Disasters and Drug Manufacturing, and more